Reversible inhibition of acetylcholinesterase by eseroline, an opioid agonist structurally related to physostigmine (eserine) and morphine
- 1 April 1982
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 31 (7) , 1233-1238
- https://doi.org/10.1016/0006-2952(82)90009-0
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Eseroline: A new antinociceptive agent derived from physostigmine with opiate receptor agonist properties. Experimental in vivo and in vitro studies on cats and rodentsNeuroscience Letters, 1981
- Opiatelike actions of eseroline, an eserine derivativeCanadian Journal of Physiology and Pharmacology, 1981
- Inhibition of [3H]naloxone binding in homogenates of rat brain by eseroline, a drug, with analgesic activity, related to physostigmineJournal of Pharmacy and Pharmacology, 1979
- Anticholinesterase Activity of Some Degradation Products of PhysostigmineJournal of Pharmaceutical Sciences, 1970
- TRITON SOLUBILIZED ACETYLCHOLINESTERASE OF BRAINJournal of Neurochemistry, 1969
- Central action of anticholinesterasesThe Journal of Physiology, 1939
- Studies in the Indole Series. V. The Complete Synthesis of Physostigmine (Eserine)Journal of the American Chemical Society, 1935
- Studies on the Relationship between Chemical Constitution and Physiological ActionBiochemical Journal, 1926
- XLII.—Physostigmine (eserine). Part IIIJournal of the Chemical Society, Transactions, 1925
- CI.—Researches on the constitution of physostigmine. Part IJournal of the Chemical Society, Transactions, 1912